WHO ICTRP trial
The Efficiency of Continuous Regional Intra-arterial Infusion in the Treatment…
ChiCTR-ONRC-12002670 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONRC-12002670 |
|---|---|
| Public title | The Efficiency of Continuous Regional Intra-arterial Infusion in the Treatment of Infected Pancreatic Necrosis |
| Scientific title | The protective mechanism of lipoxin A4 in the pancreatitis associated lung injury model: tumor necrosis factor mediated inflammatory pathways and death pathway |
| Primary sponsor | The First Affiliated Hospital of Wenzhou Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | Infected Pancreatic Necrosis |
| Interventions | control group:treated surgically;intervention group:treated by CRAI with protease inhibitors in combination of the antibiotics |
| Registration date | Aug 9, 2012 |
| Target size | control group:22;intervention group:13 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: